author={William W. Thompson and David K. Shay and Eric S. Weintraub and Lynnette Brammer and Nancy J. Cox and Larry J. Anderson and Keiji Fukuda},
  journal={Infectious Diseases in Clinical Practice},
CONTEXT Influenza and respiratory syncytial virus (RSV) cause substantial morbidity and mortality. Statistical methods used to estimate deaths in the United States attributable to influenza have not accounted for RSV circulation. OBJECTIVE To develop a statistical model using national mortality and viral surveillance data to estimate annual influenza- and RSV-associated deaths in the United States, by age group, virus, and influenza type and subtype. DESIGN, SETTING, AND POPULATION Age… 

Tables from this paper

Mortality in children from influenza and respiratory syncytial virus

Influenza and RSV account for similar numbers of deaths in children in England, but the impact varies by winter and between age groups and is considerably underestimated if analysis is restricted to respiratory certified deaths.

The Changing Epidemiology of Respiratory Syncytial Virus and Influenza: Impetus for New Control Measures

  • W. Glezen
  • Medicine
    The Pediatric infectious disease journal
  • 2004
Background: Influenza and respiratory syncytial virus (RSV) are the most important causes of medically attended acute respiratory illnesses. Medical encounters for acute respiratory illness peak each

Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013

A substantial excess mortality associated with influenza and RSV in Western Kenya is shown, especially among children <5 years and older persons with TB, supporting recommendations for influenza vaccination and efforts to develop RSV vaccines.

Influenza- and respiratory syncytial virus-associated mortality and hospitalisations

The aim of the current study was to estimate influenza- and respiratory syncytial virus (RSV)-associated mortality and hospitalisations, especially the influenza-associated burden among low-risk

Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting--South Africa, 1998-2009.

  • S. TempiaS. Walaza C. Cohen
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2014
The findings support increased research efforts to guide and prioritize interventions such as influenza vaccination and HIV prevention in low- and middle-income countries with high HIV prevalence such as South Africa.

Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018

It is suggested that, despite changes in epidemiology, endemic respiratory viruses continue to have a significant death toll in the US, especially among infants and elderly individuals.

Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons.

The number of different pathogens associated with mortality in the older population increases with increasing age, and influenza A and RSV, influenza B, parainfluenza and norovirus may also contribute substantially to elderly mortality.

Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997–2012

Respiratory syncytial virus hospitalizations in adults are increasing, likely due to increasing recognition and diagnosis, and those that are diagnosed are on average more severe.

Hospitalizations associated with influenza and respiratory syncytial virus among patients attending a network of private hospitals in South Africa, 2007–2012

Influenza and RSV substantially contributed to hospitalizations over the study period, with children <1 year and adults ≥75 years were the most affected.



Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990

  • K. Nicholson
  • Medicine, Environmental Science
    Epidemiology and Infection
  • 1996
Overall during the 15 winters the estimated mortality associated with RSV was 60–80 % more than that associated with influenza, suggesting that RSV is an important cause of winter mortality.

Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease.

A retrospective cohort study to estimate rates of hospitalizations, deaths, outpatient visits, and antibiotic courses due to influenza and RSV in persons with chronic lung disease in the Tennessee Medicaid program from 1995 to 1999 finds influenza-attributable morbidity was highest at the extremes of age.

Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997.

It was estimated that < or =510 RSV-associated deaths occurred annually during the study period, fewer than previously estimated.

Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden.

The total RSV disease burden is probably great enough to justify development of an RSV vaccine for use in this group of elderly, and the estimated annual cost of RSV pneumonia hospitalizations is $150-680 million.

Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children.

The idea that RSV is a major contributor to winter peaks in lower respiratory tract illness (LRI) deaths of infants 1-11 months old is supported.

Influenza and the rates of hospitalization for respiratory disease among infants and young children.

Infants and young children without chronic or serious medical conditions are at increased risk for hospitalization during influenza seasons, and routine influenza vaccination should be considered in these children.

Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease.

The incidence and clinical impact of RSV infection in persons with chronic obstructive pulmonary disease (COPD) and congestive heart failure who reside in the community were prospectively evaluated over two consecutive winters in 134 persons.

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults.

RSV should be considered in the differential diagnosis for adults hospitalized between November and April with community-acquired lower respiratory infection, with serologic evidence of RSV infection making RSV one of the four most common pathogens identified.